V015-6627 Screening compound: N-[4-(3-fluorobenzamido)cyclohexyl]-2-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,3-thiazole-4-carboxamide

V015-6627 Screening compound: N-[4-(3-fluorobenzamido)cyclohexyl]-2-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,3-thiazole-4-carboxamide
V015-6627 Screening compound: N-[4-(3-fluorobenzamido)cyclohexyl]-2-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,3-thiazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-6627
N-[4-(3-fluorobenzamido)cyclohexyl]-2-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,3-thiazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-6627

Molecular Formula

C28H32FN3O3S (C28 H32 FN3 O3 S)

Compound Name

N-[4-(3-fluorobenzamido)cyclohexyl]-2-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,3-thiazole-4-carboxamide

IUPAC name

N-[4-(3-fluorobenzamido)cyclohexyl]-2-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-13-thiazole-4-carboxamide

SMILES

CC(C)c(ccc(C)c1)c1OCc1nc(C(NC(CC2)CCC2NC(c2cc(F)ccc2)=O)=O)cs1

InChI

InChI=1S/C28H32FN3O3S/c1-17(2)23-12-7-18(3)13-25(23)35-15-26-32-24(16-36-26)28(34)31-22-10-8-21(9-11-22)30-27(33)19-5-4-6-20(29)14-19/h4-7,12-14,16-17,21-22H,8-11,15H2,1-3H3,(H,30,33)(H,31,34)

InChI Key

IXHSGJWSQHYMKV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19968473

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

509.64

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.046

Distribution Coefficient, logD

6.046

Water Solubility, LogSw

-5.45

Polar Surface Area

66.139

Acid Dissociation Constant (pKa)

13.27

Base Dissociation Constant (pKb)

-0.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.30

V015-6627 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

GABA Library (7115 compounds)

MCL1 Targeted Library (12200 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Eye
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with V015-6627 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-6627?
Check Price and Availability of V015-6627, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-6627 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-6627
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-6627
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-6627 available by request